Found 547774 clinical trials
Sort by:
Effects of Dual Task Training Versus Task-specific Training on Lower Limb Function, Trunk Control and Balance in Chronic Stroke Patients: A Randomized Controlled Trial
Not Applicable
Completed
- Conditions
- Stroke
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Ahmed Alshimy
- Target Recruit Count
- 45
- Registration Number
- NCT07100899
- Locations
- 🇪🇬
Al Ryada University for Science and Technology, Sadat, Menoufia, Egypt
Influence of Authorized Smokeless Tobacco Product Modified Risk Claims I: Consumer Product Demand
Not Applicable
Recruiting
- Conditions
- Smoking Behaviors
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Roswell Park Cancer Institute
- Target Recruit Count
- 160
- Registration Number
- NCT07102082
- Locations
- 🇺🇸
Roswell Park, Buffalo, New York, United States
Monitoring of Anti-TFPI in Hemophilia
Not yet recruiting
- Conditions
- HemophiliaRebalancing AgentsProphylaxis
- Interventions
- Biological: blood sampling
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Hospices Civils de Lyon
- Target Recruit Count
- 11
- Registration Number
- NCT07101926
- Locations
- 🇫🇷
Groupement hospitalier Est Hôpital Cardilogique Service d'hémostase clinique, Bron, France
🇫🇷Centre de Référence Hémophilie et autres déficits rares en protéine de la coagulationCentre de Traitemendes Hémophiles F. Josso, Paris, France
In-situ Clinical Trial Assessing Ability to Detect and Monitor Active Caries and Their Remineralization
Not Applicable
Not yet recruiting
- Conditions
- Dental Caries
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Incisive Technologies Pty Ltd
- Target Recruit Count
- 12
- Registration Number
- NCT07100626
Neonatal Neurodevelopmental Outcomes
Not yet recruiting
- Conditions
- Food InsecurityDepressionAnxietyStress
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Baylor College of Medicine
- Target Recruit Count
- 200
- Registration Number
- NCT07101757
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
Comparing Sarcopenia, Physical, Psychological and Social Frailty in Hospitalized Older Women CHF in Metropolitan and Rural Settings
Not Applicable
Not yet recruiting
- Conditions
- 65 Years OlderCHF - Congestive Heart FailureSocial CommunicationSarcopenia in Elderly
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Chang Gung University of Science and Technology
- Target Recruit Count
- 200
- Registration Number
- NCT07100366
A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma
Not Applicable
Not yet recruiting
- Conditions
- Cutaneous Squamous Cell Carcinoma (CSCC)Renal TransplantSolid TumorSolid Tumor Cancer
- Interventions
- Drug: tolododekin alfa
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Ankyra Therapeutics, Inc
- Target Recruit Count
- 20
- Registration Number
- NCT07100925
OR6A2 on Monocytes and Cardiovascular Outcomes in Myocardial Ischemia-Reperfusion Injury
Recruiting
- Conditions
- Myocardial Ischemia-Reperfusion Injury
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Southeast University, China
- Target Recruit Count
- 200
- Registration Number
- NCT07100457
- Locations
- 🇨🇳
Department of Cardiology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu, China
Phase I Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RSS0343 Tablets in Healthy Subjects After Single and Multiple Oral Administration and the Effect of Food on the Pharmacokinetics of RSS0343
Not Applicable
Completed
- Conditions
- Health Volunteer
- Interventions
- Drug: RSS0343 tablets ；placebo
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Target Recruit Count
- 72
- Registration Number
- NCT07101965
- Locations
- 🇨🇳
The First Affiliated Hospital of Shandong First Medical University (Qianfoshan Hospital), Shandong, Jinan, China
A PHASE II, RANDOMIZED TRIAL TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT VULVAR CANCER
- First Posted Date
- 2025-08-03
- Last Posted Date
- 2025-08-03
- Lead Sponsor
- Hospital Israelita Albert Einstein
- Target Recruit Count
- 42
- Registration Number
- NCT07101848
- Locations
- 🇧🇷
Hospital Israelita Albert Einstein, São Paulo, SP, Brazil